US 10934302
SHP2 phosphatase inhibitors and methods of use thereof
granted A61PA61P35/00
Quick answer
US patent 10934302 (SHP2 phosphatase inhibitors and methods of use thereof) held by Relay Therapeutics, Inc. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00